Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Extracellular vesicles proteome from Faecalibacterium duncaniae A2-165 in response to hydrogen peroxyde stress

ABSTRACT: Faecalibacterium duncaniae A2-165 was incubated in the presence or absence of 440 µM H₂O₂, and extracellular vesicles were isolated from the cell-free supernatant for comparative proteomic analysis limited to protein identification to evaluate the impact of oxidative stress.

INSTRUMENT(S):

ORGANISM(S): Faecalibacterium Prausnitzii A2-165 Bacteria

SUBMITTER: Sandrine Auger

LAB HEAD: Sandrine Auger

PROVIDER: PXD073554 | Pride | 2026-05-05

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E__Marilina_20251024_58_Auger_11-7-2025_Ctrol_1_resusp10_13697_d.zip	Other
	E__Marilina_20251024_58_Auger_11-7-2025_H2O2_1_resusp10_13699_d.zip	Other
	E__Marilina_20251024_58_Auger_11-7-2025_H2O2_2_resusp10_dil2_13701_d.zip	Other
	E__Marilina_20251024_58_Auger_11-7-2025_H2O2_3_resusp10_dil2_13695_d.zip	Other
	E__Marilina_20251024_58_Auger_11-8-2025_Ctrol_2_resusp10_dil3_13705_d.zip	Other

Items per page:

1 - 5 of 26

Similar Datasets

Identification of a 144-amino-acid Scaffold Protein for Extracellular Vesicle Engineering

Project description:Extracellular vesicles (EVs) have emerged as promising drug-delivery vehicles. Genetic engineering of a membrane-bound, EV-sorting scaffold protein empowers these cell-borne nanosized vesicles by installing targeting moieties on the surface and enriching therapeutic cargo in the lumen. However, the choice of scaffold proteins with a simple structure and short sequence is scarce. Here, we conduct mass-spectrometry-based proteomic studies, identify 15 candidate proteins with EV-sorting properties, and examine their capability as the scaffold protein. ENPP1 stands out from our screening, outperforming the widely used EV-sorting proteins PTGFRN and Lamp2b with high abundance, homogeneity, stability, and engineerability. In particular, a 144-amino acid truncated version of ENPP1, called EN144 here, demonstrates high-density loading of cargos, including peptides, proteins, and mRNAs. Based on this finding, we engineer decoy EVs expressing IL-6 signal transducer (IL6ST, a.k.a. gp130) fused with EN-144, EN144-EVhgp130, to inhibit the IL-6 trans-signaling pathway. The resulting decoy EVs elicit potent anti-inflammatory effects and improve the survival rate of septic mice. Chondrocyte-targeting EN144-EVhgp130 ameliorates inflammation and remodels the synovial tissue microenvironment of cartilage in a rat model of osteoarthritis (OA), surpassing tocilizumab (TCZ), the clinically approved humanized anti-interleukin-6 receptor (IL-6R) antibody. Altogether, we report the identification and verification of EN144 as one of the smallest and simplest scaffold proteins for EV engineering and showcase systematic and local administrations of EN144-engineered decoy EVs for treating inflammatory diseases.

2026-04-27 | PXD057965 | Pride

Proteomics analysis of extracellular vesicles purified by heparin chromatography.

Project description:Extracellular vesicles (EVs) were isolated from U2OS cell (Human) conditioned medium (Input) was fractionated into two subpopulations named non-heparin binding (NHB) and heparin-binding (HB). Proteomics analysis was performed on Input, NHB and HB samples. The two main goals for this analysis are: first, do a proteomics profiling study to identify proteins present in each of the 3 samples; second, perform quantitative analysis of the level of identified proteins in the samples and investigate if there is a certain enrichment pattern differences in samples "NHB" and "HB". Three biological replicates are included.

2023-06-13 | PXD039845 | Pride

Proteomic profile of healthy human monocytes differentiated to macrophages with non-tumor or tumor cell-derived extracellular vesicles

Project description:To investigate the impact of tumor cell-derived extracellular vesicles on monocyte-macrophage differentiation, healthy monocytes were treated with EVs derived from two different pancreatic cancer cell lines and a non-tumoral pancreatic ductal epithelial cell line. Following differentiation to macrophages, proteomic analyses by mass spectrometry were performed on cells.

2026-06-11 | PXD039439 | Pride

DIA quantitative proteomics-QseB

Project description:We perform proteomic analysis on the parent strain SC1401 and the ΔqseB gene deletion mutant under standard growth conditions. The proteomic data will provide useful insights for the whole-system modeling of signal transduction and gene transcription regulation. This serves as an important foundation for further research into the role of QseB during Glaesserella parasuis infection, the pathogenic mechanisms of Glaesserella parasuis, as well as its prevention and control.

2026-05-29 | PXD065386 | Pride

Head and neck squamous cell carcinoma extracelular vesicles proteome LC-MS

Project description:Monitoring of changes in the proteomic composition of extracellular vesicles produced by head and neck squamous cell carcinoma cells after exposure to agents affecting autophagic and lysosomal processes. LC-MS analysis of phosphatidylserine-positive budding EVs.

2023-05-25 | PXD037164 | Pride

Ultra-sensitive metaproteomics (uMetaP) redefines the “dark” metaproteome, enables single-bacterium resolution, and discovers hidden functions in the gut microbiome

Project description:Metaproteomics uniquely characterizes host-microbiome interactions. However, most species detected by metagenomics remain hidden to metaproteomics due to sensitivity limits. We present a novel ultra-sensitive metaproteomic solution (uMetaP) that, for the first time, reaches full-length 16S rRNA taxonomic depth and can simultaneously decipher functional features. Querying the mouse gut microbiome, uMetaP achieved unprecedented performance in key metrics like protein groups (47925) alongside taxonomic (220 species) and functional annotations (223 KEGG pathways) - all within 30-min analysis time and with high reproducibility, sensitivity, and quantitative precision. uMetaP revealed previously unidentified proteins of unknown functions, small proteins, and potentially new natural antibiotics. Leveraging the extreme sensitivity of uMetaP and SILAC-labelled bacteria, we revealed the true limit of detection and quantification for the “dark” metaproteome of the mouse gut. Moreover, using a two-bacteria proteome mix, we demonstrated single-bacterium resolution (500 femtogram) with exceptional quantification precision and accuracy. From deciphering the interplay of billions of microorganisms with the host to exploring microbial heterogeneity, uMetaP represents a quantum leap in metaproteomics. Taken together, uMetaP will open new avenues for our understanding of the microbial world and its connection to health and disease.

2025-06-25 | PXD051792 | Pride

Generation of peptide detectability datasets]{Generation of peptide detectability datasets from single DIA spectra for prediction model fine-tuning - MS2 quant

Project description:Knowing which peptide can be detected during a mass spectrometry based proteomics analysis is a valuable information. Detectability prediction models predict detectability based on peptides amino acid sequences. Since peptide detectability varies substantially across different instruments, acquisition methods, and experimental conditions, sequence-based models alone cannot account for these sources of variability. Recent state-of-the-art methods address this transferability limitation by fine tuning specific models for each experimental setup. Nonetheless, these methods rely on significantly large training detectability datasets attaining 300k peptides, which incurs substantial costs both in terms of acquisition and processing times. In this study we propose a complementary method to infer detectability dataset from a single DIA spectrum. Such datasets can then be used to fine-tune prediction models from limited raw data while improving transferability to any specific setup. The associated goal is to further promote the use of detectability models in proteomics pipelines by cutting the underlying costs. For instance, we show that filtering search libraries based on predicted detectability simultaneously improve peptide identification and reduce computing time. This project replicates the results of PXD069521 with different quantification methods.

2026-07-02 | PXD076276 | Pride

The combined action of suicide gene exosomes from pancreatic cancer-associated fibroblasts and from mesenchymal stem cells as a pancreatic ductal adenocarcinoma treatment approach

Project description:Exosomes from pancreatic cancer-associated fibroblasts and mesenchymal stem cells that have been transduced with the yeast cytosine deaminase::uracil phosphoribosyl transferase release suicide gene exosomes acting as "Trojan horse" drugs, effectively killing pancreatic cancer cells by converting the non-toxic prodrug 5-fluorocytosine intracellularly into the cytotoxic 5-fluorouracil. We have shown in experiments in vitro, involving a simulated desmoplastic pancreatic tumor, that the combined action of these targeted exosomes could be an approach for pancreatic ductal adenocarcinoma treatment.

2025-08-08 | PXD059055 | Pride

TGF-β signaling activation modulates the biology of tumor-derived extracellular cellular vesicles

Project description:Tumor-derived extracellular vesicles (EVs) have been associated with cancer progression and metastasis due to the transfer of bioactive molecules in between the tumor microenvironment. Although Transforming Growth Factor-β (TGF-β) signaling associated molecules have been implicated as cargo of EVs, the role of TGF-β pathway on EV’s biology to promote tumorigenesis is poorly understood. Hence, we aimed to describe the impact of TGF-β signaling on biogenesis and functional transfer of cargo from tumor-derived EVs induced by TGF-β (EV+TGF-β1). To this end, EV-fractions enriched in CD81 or Cholerae toxin B chain (CTB) were isolated from the vesicular secretome fraction (VSF) of human breast cancer and lung adenocarcinoma cells and further characterized.

2025-05-06 | PXD039591 | Pride

Comparison of EVs isolated from human plasma using different methods

Project description:Comparison of different EV isolation methods for their proteomic coverage

2025-06-16 | PXD058948 | Pride